OBJECTIVES: Surgical septal myectomy is performed to relieve left ventricular outflow tract narrowing in severe drug-refractory obstructive hypertrophic cardiomyopathy. The objective of this study was to assess the perioperative and long-term clinical outcome of this procedure performed during infancy.
INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is defined as left ventricular hypertrophy with or without diastolic and systolic ventricular dysfunction, arrhythmias and histopathological changes, such as myocardial fibrosis and myocyte disarray. HCM can be associated with inborn errors of metabolism or with syndromes, such as Noonan syndrome spectrum [1] . Non-syndromic HCM can be inherited, with mutations in sarcomere genes being the most common underlying aetiology [2] . Left ventricular (LV) outflow tract (LVOT) obstruction occurs in about one-third of patients with HCM and is either due to an extensive hypertrophy of the interventricular septum or to a systolic anterior motion of the anterior mitral valve leaflet. Treatment options include pharmacological therapy, usually beta-blockers and/or the negative inotropic antiarrhythmic disopyramide, surgery, ablation or dual-chamber pacing [3] . Surgical septal myectomy is the gold standard for the relief of drug-refractory symptoms in patients with obstructive HCM [4, 5] and improves survival, exercise capacity and quality of life in those patients [6, 7] .
The underlying aetiology of infants presenting with HCM differs from older children and adults in that there is a high prevalence of syndromic or metabolic HCM in this age group [8] . Surgery in these infant patients might have different effects, given distinct disease aetiology, smaller body size and different physiology compared with older children or adults.
There is limited data addressing the clinical outcome of surgical septal myectomy in infants with obstructive HCM.
The aim of this single-centre study was to compare the perioperative and long-term clinical outcomes of children with severe drug-refractory obstructive HCM requiring surgical septal myectomy during infancy (1 year of age and less [9, 10] ) with outcome of children undergoing myectomy between 1 and 18 years of age.
PATIENTS AND METHODS
Between January 1978 and December 2015, a total of 55 patients were diagnosed with paediatric onset HCM at the German Heart Centre Munich, a tertiary care university hospital.
Demographic, clinical, echocardiographic, electrocardiographic, surgical and other patient-related data were collected by chart review from 23 consecutive patients with HCM undergoing surgical septal myectomy during childhood (< _18 years of age).
Patients were contacted and invited to undergo a detailed outpatient visit including clinical examination, transthoracic echocardiography, electrocardiogram (ECG), 24-h ambulatory (Holter) ECG, cardiopulmonary exercise testing (CPET) and cardiovascular magnetic resonance (CMR) imaging. Blood samples were sent for genetic testing as recommended by the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) guidelines from 2011, if not yet genetically diagnosed [3, 11] .
Patients were classified into 2 groups for comparison: Group A of 12 children requiring surgical septal myectomy already during infancy (< _1 year of age [9, 10] ) and Group B of 11 children undergoing myectomy between 1 and 18 years of age.
The diagnosis of HCM in all of the patients was based on clinical evaluation and cardiac catheterization (in the earlier years prior to the possibility of accurate imaging by echocardiography) or echocardiography detecting myocardial hypertrophy in the absence of another cardiac or systemic disease that would cause the degree of LV hypertrophy identified [5, 12] . Definition of LVOT obstruction and indication for surgery was according to the definition of the committee of the German Society of Paediatric Cardiology (DGPK) and the guidelines of the AMA [3, 13] .
Detailed information regarding patient recruitment, LVOT definition, indication for surgery, surgical technique, transthoracic echocardiography, ECG, CPET, CMR and quality of life assessment are provided in Supplementary Material.
Ethical approval
This study was approved by the Technical University of Munich Institutional Review Board, and all patients or parents gave written informed consent.
Statistics
Statistical analysis was performed with the SPSS software version 22 
RESULTS

Patient characteristics
Six patients had undergone septal myectomy before the year 2000 and 17 patients between 2001 and 2015 (Supplementary Material, Table S1 ). Half of the patients underwent transaortic septal myectomy for obstructive HCM during infancy (Group A) and half between 1 and 18 years of age (Group B). The underlying genetic diagnosis was Noonan spectrum, mainly presented in Group A, or non-syndromic HCM secondary to sarcomere mutations (Fig. 1) . Baseline preoperative data are listed in Table 1 . Besides a lower body surface area in Group A, preoperative demographic data did not differ significantly between both groups. The majority of patients were in New York Heart Association (NYHA) or Ross functional Class III or IV before surgery. Medication before surgery was mainly beta-blocker therapy in both groups (Supplementary Material, Tables S1 and S2).
Perioperative outcome
Perioperative data are listed in Table 2 . Surgical myectomy was the first intervention in all patients, except for 1 patient in Group A with prior aortic valve balloon dilatation for congenital aortic stenosis. No patient required an implantable cardioverter-defibrillator or pacemaker prior to surgery. Concomitant surgical procedures were performed more frequently in Group A, with right ventricular outflow tract resection and septal defect closures being the most common. Total duration of surgery was shorter in Group A, but aortic cross-clamp and bypass times did not differ between groups. One patient in Group A, with Noonan syndrome and multiple lentigines, died in the immediate postoperative period from heart and multiorgan failure. There was a trend towards perioperative complications, such as arrhythmias and pleural effusions, occurring more frequently in Group B, but this did not reach statistical significance, possibly due to small numbers. Patients in Group A received more homologous blood transfusions compared to patients in Group B.
Comparison of preoperative and early postoperative echocardiographic results is presented in Table 3 . Myocardial hypertrophy and LVOT gradients were similar between groups before surgery. Surgical septal myectomy reduced LVOT gradient significantly in both groups, but resting gradient in the early postoperative period was higher in Group A when compared with Group B. Surgical myectomy resulted in a significant reduction of systolic anterior motion.
Long-term outcome
Long-term follow-up data at a mean time of 8.9 ± 8.2 years after myectomy were obtained in 19 patients and are depicted in Table 4 . No long-term follow-up data were obtained in 3 patients who were lost to follow-up and in 1 patient who died perioperatively.
Two patients died during long-term follow-up: 1 patient in Group A with unknown underlying genetic aetiology and additional ventricular pre-excitation died of sudden cardiac death 2.1 years after first myectomy (1.1 year after redo myectomy); 1 patient in Group B died of intractable chronic heart failure and third-degree atrioventricular (AV) block 18.4 years after surgery while waiting for heart transplantation ( Fig. 2) .
Two patients in Group A required reoperation at 0.9 and 6.5 years after operation, respectively, because of persistent or increasing LVOT obstruction, both showing ventricular pre-excitation. There was no death related to reoperation.
In both groups, most patients were in clinically improved condition on long-term follow-up: they were classified in NYHA/ Ross functional Class I or II. As assessed on CPET, objective exercise capacity was similar between groups.
In both groups, total medication use was unchanged on longterm follow-up when compared to preoperative medication use (Supplementary Material, Table S3 ).
Quality of life as assessed by the SF-36 or KINDL-R questionnaire was normal to above average in both groups (Supplementary Material, Figs. S1 and S2).
Apart from the 2 patients in Group A requiring reoperation, there was a long-lasting reduction of the interventricular septal thickness and of the LVOT gradient in both groups (Fig. 3) . Also in both groups, about one-third of patients had persistent systolic anterior motion of the mitral valve associated with moderate mitral valve regurgitation in the long term. One patient in Group B and 1 in Group A demonstrated new moderate aortic valve regurgitation on late follow-up, not requiring intervention. Both developed over time and were not already present at early postoperative follow-up.
There were no significant differences between the 2 groups concerning 12-lead ECG parameters on long-term follow-up (Supplementary Material, Table S3 ). Two patients from Group B demonstrated arrhythmias, such as non-sustained ventricular or supraventricular tachycardia or high occurrence of premature ventricular or supraventricular contractions on 24 h-Holter and CPET recordings on long-term follow-up, but one of them had already been present before surgery.
Two patients from Group B demonstrated higher degree AV block on long-term follow-up. One of those occurred during terminal heart failure. The other patient having intermittent ventricular pre-excitation required an implantable cardioverter-defibrillator implantation 8 years after operation because of recurrent cardiac syncopes induced by alternating transition of supraventricular tachycardia and third-degree AV block leading to severe bradycardia. 
Pathological myocardial changes on long-term follow-up
CMR was performed in a subset of 9 patients (4 in Group A and 5 in Group B) on long-term follow-up. Focal fibrosis, as assessed by late gadolinium enhancement, was present in 4 patients (1 in Group A and 3 in Group B). The location of focal fibrosis was mostly at the septal wall of the left ventricle, without significant differences between both groups. Increased interstitial fibrosis, as assessed by the measurement of extracellular volume fraction (ECV) on CMR T1 mapping, was noted in both groups. There was no difference between the septal and the myocardial amount of interstitial fibrosis.
DISCUSSION
This study is the first to evaluate the detailed perioperative and clinical long-term outcome of surgical septal myectomy performed in infants at 1 year of age or less with HCM and severe clinical signs of LVOT obstruction. In terms of the perioperative outcome, including mortality, quality of life, echocardiographic and electrocardiographic variables, the present results are consistent with previous studies reporting a favourable outcome in older children [14] [15] [16] [17] .
The main diagnosis in infants undergoing surgical septal myectomy for severe obstructive HCM was Noonan syndrome or Noonan syndrome with multiple lentigines. In general, children with Noonan syndrome and HCM during infancy experience a higher mortality and morbidity compared to children with nonsyndromic HCM [1, 8] . However, the results of this study as well as recently described clinical outcomes of children with Noonan syndrome and symptoms of obstructive HCM undergoing septal myectomy at an older age [18] confirm that this intervention can be safely performed in this patient population, even during infancy. This finding is of importance for clinical management of this subset of children who often present with medically refractory clinical signs of heart failure very early in life [8, 19] .
More concomitant cardiac procedures, such as additional right ventricular outflow tract resection or septal defect closures, were performed in the group undergoing surgical myectomy during infancy. This can be explained by the fact that Noonan syndrome is frequently associated with other congenital cardiac defects [20] . However, this neither prolonged cardiac bypass or aortic cross-clamp time nor did it result in more perioperative complications.
Infants undergoing surgical septal myectomy received more intraoperative homologous blood transfusion compared to older children undergoing the same procedure. This is certainly due to the need for priming the cardiopulmonary bypass circuit with blood products associated with patients in this age group [21] .
Transaortic septal myectomy may be challenging in infants because of limited exposure through the aortic valve annulus [14] . Damage to the aortic valve cusps may necessitate subsequent aortic valve replacement. There was no increased incidence of severe aortic valve regurgitation or aortic valve replacement in infants undergoing myectomy in this study when compared with older children.
Because of the small patient size, it might be challenging to accurately judge the depth and length of the septal myectomy in infants. Thus, an inadequate excision will leave residual LVOT obstruction and might require repeat septal myectomy [14] . In line with this, infants undergoing septal myectomy had higher postoperative LVOT gradients compared to older children in this study. Also, even though it was not statistically significant, it was of note that 2 patients of the infant but none of the older age group required surgical redo myectomy later in life.
For the same reason, septal myectomy during infancy might result in postoperative AV or bundle-branch block [14] . This study did not show an increased incidence of those electrophysiological postoperative complications in infants compared with older children undergoing this procedure.
Remarkably, 3 patients, 2 in Group A and 1 in Group B, showed ventricular pre-excitation leading to worse long-term outcome of surgical septal myectomy: 1 received an implantable-cardioverter defibrillator and 2 required reoperation, of whom 1 died of sudden cardiac death afterwards. HCM associated with ventricular pre-excitation is a pathognomic feature of glycogen storage HCM caused by mutations in the PRKAG2 gene [22] . This might have been the underlying aetiology of the one patient in this study who presented with a severe form of cardiomyopathy and died suddenly after the second septal myectomy. The genetic diagnosis of the patient was not known. Ventricular pre-excitation has been described in patients with sarcomere mutations [23] as well as in patients with LEOPARD syndrome [24] , but those are only case reports and data are lacking about associations with worse clinical outcome in those patients. The data of this study suggest that HCM and ventricular pre-excitation might generally be associated with a more severe disease phenotype as compared to HCM without electrophysiological abnormalities.
Long-lasting postoperative relief of the LVOT obstruction has previously been described for older children undergoing surgical septal myectomy [14, 15, 18] . Comparable to these findings, this study shows a long-lasting postoperative relief of the LVOT obstruction associated with improved clinical status also in patients undergoing this surgery during infancy. In addition to that, normal-to-above average self-perceived quality of life could reasonably be demonstrated in both groups on detailed clinical follow-up outpatient visit. However, analysis of postoperative medical therapy shows that surgery does not abandon continued medical needs in the children's life.
In this study, CMR was used to assess pathological myocardial remodelling, such as focal and interstitial fibrosis, by late gadolinium enhancement [25] and by assessing the ECV on CMR T1 mapping [26] , respectively. As there are no existing normative data of ECV in healthy children, the values in this study were referred to normative data in an adult population [27] . Compared to the values described in the literature, total ECV was elevated in both groups with no significant difference between groups. Also, while carefully avoiding the inclusion of scar tissue into measurements, ECV was similar in the septal region compared with the general myocardial tissue, suggesting that there is no increased inflammatory response causing pathological remodelling in the surgical area, even if surgery was performed at an early age. Analogously, focal fibrosis as assessed by late gadolinium enhancement was seen in a similar amount in the infant compared to the older children group. The main septal location of focal fibrosis might be explained by scar tissue developing due to surgical intervention.
Limitations
There are limitations to this study. First, this is a single-centre study with retrospective data analysis, and the results cannot be extrapolated to other centres. Second, complete clinical followup data and genetic diagnosis were not available for the entire study population. Third, histopathological analysis is the gold standard for assessing pathological myocardial remodelling. However, since cardiac catheterization is not performed in children with HCM for routine follow-up, CMR findings were used in this study for assessing the amount and distribution of local and interstitial fibrosis. Despite good correlation of imaging and histopathological changes [28] , this might not reflect true cellular myocardial changes. Furthermore, medical management, in particular beta-blocker dosing, changed over time [29] , which resulted in a smaller percentage of children undergoing surgery (Supplementary Material, Table S1 ). However, this had no impact on the results of this study which focused on operated children only. Lastly, statistical tests often did not reveal significance, given small patient numbers. P-values close to 0.05 were interpreted as 'trends' and need further evaluation.
CONCLUSION
In conclusion, surgical septal myectomy performed during infancy is a safe procedure with low mortality and morbidity, but with a trend towards a higher reoperation rate later in life. Despite the differences in underlying genetic aetiology, patient size and physiology, there is, in general, a favourable long-lasting clinical outcome in most of the patients.
